Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states

[1]  Patricia A. Lovelace,et al.  Defective Signaling in the JAK-STAT Pathway Tracks with Chronic Inflammation and Cardiovascular Risk in Aging Humans. , 2016, Cell systems.

[2]  Xueyuan Bai,et al.  The Expression Changes of Inflammasomes in the Aging Rat Kidneys. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  R. Vance,et al.  NAIP proteins are required for cytosolic detection of specific bacterial ligands in vivo , 2016, The Journal of experimental medicine.

[4]  M. Waldenberger,et al.  Molecular Characterization of the NLRC4 Expression in Relation to Interleukin-18 Levels , 2015, Circulation. Cardiovascular genetics.

[5]  M. Suematsu,et al.  Inflammation, But Not Telomere Length, Predicts Successful Ageing at Extreme Old Age: A Longitudinal Study of Semi-supercentenarians , 2015, EBioMedicine.

[6]  Mark M. Davis,et al.  Cytomegalovirus infection enhances the immune response to influenza , 2015, Science Translational Medicine.

[7]  E. Hagström,et al.  NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO) , 2015, Circulation. Cardiovascular genetics.

[8]  D. Talwar,et al.  Systemic Inflammation Predicts All-Cause Mortality: A Glasgow Inflammation Outcome Study , 2015, PloS one.

[9]  Ruslan Medzhitov,et al.  Homeostasis, Inflammation, and Disease Susceptibility , 2015, Cell.

[10]  S. Larsson,et al.  Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. , 2014, American journal of epidemiology.

[11]  D. Harrison,et al.  DC isoketal-modified proteins activate T cells and promote hypertension. , 2014, The Journal of clinical investigation.

[12]  John P. Overington,et al.  An atlas of genetic influences on human blood metabolites , 2014, Nature Genetics.

[13]  J. Steven Leeder,et al.  A modified generalized Fisher method for combining probabilities from dependent tests , 2014, Front. Genet..

[14]  Mark M. Davis,et al.  Effects of Aging, Cytomegalovirus Infection, and EBV Infection on Human B Cell Repertoires , 2014, The Journal of Immunology.

[15]  Susumu Goto,et al.  Data, information, knowledge and principle: back to metabolism in KEGG , 2013, Nucleic Acids Res..

[16]  Mark M. Davis,et al.  Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination , 2013, Proceedings of the National Academy of Sciences.

[17]  R. Flavell,et al.  Adenosine is required for sustained inflammasome activation via the A2A receptor and the HIF-1α pathway , 2013, Nature Communications.

[18]  A. Weyrich,et al.  Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. , 2013, Blood.

[19]  D. Ingram,et al.  Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. , 2013, Cell metabolism.

[20]  V. Burt,et al.  Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. , 2013, NCHS data brief.

[21]  J. Thakar,et al.  Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations , 2013, Nucleic acids research.

[22]  Mark M. Davis,et al.  Apoptosis and other immune biomarkers predict influenza vaccine responsiveness , 2013, Molecular Systems Biology.

[23]  Mark M. Davis,et al.  Apoptosis and other immune biomarkers predict influenza vaccine responsiveness , 2013, Molecular systems biology.

[24]  G. B. Louis,et al.  The role of inflammation in age-related disease , 2013, Aging.

[25]  Vishva M Dixit,et al.  Inflammasomes and their roles in health and disease. , 2012, Annual review of cell and developmental biology.

[26]  Ruslan Medzhitov,et al.  Evolution of Inflammatory Diseases , 2012, Current Biology.

[27]  Qinglian Liu,et al.  Activation of Nod-Like Receptor Protein 3 Inflammasomes Turns on Podocyte Injury and Glomerular Sclerosis in Hyperhomocysteinemia , 2012, Hypertension.

[28]  J. Tschopp,et al.  NLRC5 Deficiency Selectively Impairs MHC Class I- Dependent Lymphocyte Killing by Cytotoxic T Cells , 2012, The Journal of Immunology.

[29]  L. Zitvogel,et al.  Inflammasomes in carcinogenesis and anticancer immune responses , 2012, Nature Immunology.

[30]  G. Ricevuti,et al.  Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. , 2011, Autoimmunity reviews.

[31]  Xiangmei Zhou,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[32]  R. Scrivo,et al.  Inflammation as "common soil" of the multifactorial diseases. , 2011, Autoimmunity reviews.

[33]  J. Tschopp,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[34]  David S. Wishart,et al.  Bioinformatics Applications Note Systems Biology Metpa: a Web-based Metabolomics Tool for Pathway Analysis and Visualization , 2022 .

[35]  Yasmin,et al.  Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’ , 2010, European heart journal.

[36]  S. Douma,et al.  Platelet activation in essential hypertension: implications for antiplatelet treatment. , 2010, American journal of hypertension.

[37]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[38]  Pamela J Green,et al.  tRNA cleavage is a conserved response to oxidative stress in eukaryotes. , 2008, RNA.

[39]  D. Koller,et al.  The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.

[40]  D. Fearon,et al.  Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist. , 2008, Circulation.

[41]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[42]  N. Volkmann,et al.  Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. , 2007, Molecular cell.

[43]  T. Ogihara,et al.  An intronic variable number of tandem repeat polymorphisms of the cold-induced autoinflammatory syndrome 1 (CIAS1) gene modifies gene expression and is associated with essential hypertension , 2006, European Journal of Human Genetics.

[44]  Ziv Bar-Joseph,et al.  STEM: a tool for the analysis of short time series gene expression data , 2006, BMC Bioinformatics.

[45]  James R. Johnson,et al.  Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.

[46]  C. Patrono,et al.  Determinants of Platelet Activation in Human Essential Hypertension , 2004, Hypertension.

[47]  D B Kell,et al.  Oscillations in NF-kappaB signaling control the dynamics of gene expression. , 2004, Science.

[48]  D. Pe’er,et al.  Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data , 2003, Nature Genetics.

[49]  Richard A. Preston,et al.  Effects of Severe Hypertension on Endothelial and Platelet Microparticles , 2003, Hypertension.

[50]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[51]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Burmester,et al.  Preactivated peripheral blood monocytes in patients with essential hypertension. , 1999, Hypertension.

[53]  T. Niwa,et al.  RNA metabolism in uremic patients: accumulation of modified ribonucleosides in uremic serum. Technical note. , 1998, Kidney international.

[54]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[55]  J. Miners,et al.  Assessment of caffeine exposure: Caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines , 1986, Clinical pharmacology and therapeutics.